Core Viewpoint - The announcement details the share pledge and release activities of Shandong Haodangjia Marine Development Co., Ltd.'s controlling shareholder, Haodangjia Group, indicating a significant portion of shares are pledged while also highlighting the group's financial stability and the lack of adverse effects on the company’s operations and governance [2][4][11]. Shareholding and Pledge Details - Haodangjia Group holds a total of 555,550,990 shares in the company, representing 38.03% of the total share capital of 1,460,994,304 shares [2][7]. - The cumulative number of pledged shares by Haodangjia Group is 345,541,400 shares, which accounts for 62.20% of its holdings and 23.65% of the company's total share capital [2][10]. - On January 13, 2026, Haodangjia Group released 10,200,000 shares from pledge, which is 1.84% of its holdings and 0.70% of the total share capital [2][3]. Future Pledge Obligations - In the next six months, Haodangjia Group has 105,100,000 shares maturing, which is 18.92% of its holdings and 7.19% of the total share capital, with a corresponding financing balance of 11.6 million [3][10]. - Within the next year, including the six-month period, the total number of shares maturing is 220,100,000, representing 39.62% of its holdings and 15.07% of the total share capital, with a financing balance of 26.1 million [3][10]. Financial Stability and Impact on Operations - Haodangjia Group is reported to have a good credit status and the ability to repay its debts, indicating that the pledge risks are manageable and will not lead to a change in the company's actual control [3][11]. - The stock pledge is not expected to have a significant impact on the company's main business, financing costs, or operational sustainability, nor will it affect the independence of the company or its governance structure [4][13].

Core Viewpoint - China Everbright Bank has announced several related party transactions involving credit facilities and loans to companies controlled by its parent, China Everbright Group, totaling RMB 31.54 billion over the past 12 months, which exceeds 0.5% of the bank's latest audited net assets [3][5][10]. Summary by Sections Transaction Overview - The bank has approved a comprehensive credit limit of RMB 354 million for Jiasitang Pharmaceutical Co., Ltd. with a term of 24 months [2][5]. - A bilateral non-committed revolving loan of RMB 500 million has been approved for Everbright Securities International with a term of 360 days [2][6]. - A comprehensive credit limit of RMB 1.4 billion has been approved for Everbright Jinou Asset Management Co., Ltd. with a term of 3 years, along with a single batch credit limit of RMB 900 million for 24 months [2][6]. Related Party Transactions - The transactions with Jiasitang Pharmaceutical, Everbright Securities International, and Everbright Jinou are classified as related party transactions as they are controlled by China Everbright Group [2][7]. - The total amount of related party transactions with China Everbright Group and its subsidiaries in the past 12 months is RMB 31.54 billion, excluding previously disclosed transactions [3][5]. Approval Process - The transactions with Jiasitang Pharmaceutical and Everbright Securities International have been filed with the board's related party transaction control committee and do not require further approval from the board or shareholders [3][11]. - The transaction with Everbright Jinou has been reviewed and approved by the board's related party transaction control committee and independent directors, and does not require shareholder approval [3][11]. Financial Impact - The related party transactions are considered normal business operations for the bank and are not expected to have a significant impact on its financial condition [10][12].

Group 1 - The company plans to repurchase shares using a budget of no less than RMB 300 million and no more than RMB 600 million, at a price not exceeding RMB 26.00 per share, through centralized bidding within 12 months from the approval date [1] - The company has obtained a loan commitment letter from China Merchants Bank Foshan Branch for a stock repurchase loan amounting to RMB 540 million, which will cover up to 90% of the actual repurchase amount [1][2] - The loan is designated for the specific purpose of repurchasing the company's shares and has a term of 36 months [1][3] Group 2 - The loan commitment letter is effective for 12 months from the date of issuance [2] - The company will adhere to relevant regulations and make repurchase decisions based on market conditions and available funds, while ensuring timely disclosure of progress to investors [3]

Group 1: Company News - Rongbai Technology signed a procurement cooperation agreement with CATL for lithium iron phosphate cathode materials, with a total sales amount exceeding 120 billion yuan, supplying 3.05 million tons from Q1 2026 to 2031 [10][11] - Baiwei Storage expects a net profit attributable to shareholders of 850 million to 1 billion yuan in 2025, representing a year-on-year increase of 427.19% to 520.22% [5] - Dazhu CNC anticipates a net profit attributable to shareholders of 785 million to 885 million yuan in 2025, reflecting a year-on-year growth of 160.64% to 193.84% [6] - TCL Technology forecasts a net profit attributable to shareholders of 4.21 billion to 4.55 billion yuan in 2025, indicating a year-on-year increase of 169% to 191% [6] - Hengdi Pharmaceutical expects a net profit attributable to shareholders of 31 million to 39 million yuan in 2025, showing a decline of 57.40% to 66.14% [9] - *ST Wanfang anticipates a revenue below 300 million yuan in 2025, with net profit expected to be negative, leading to potential delisting [10] Group 2: Industry Developments - The State Grid reported that inter-provincial electricity trading volume reached 1.67 trillion kWh in 2025, a 10% year-on-year increase, with renewable energy trading volume up 41% to 317.7 billion kWh [2] - The Ministry of Industry and Information Technology released an action plan for the high-quality development of industrial internet platforms from 2026 to 2028, aiming for over 450 influential platforms and a core industry scale exceeding 1.6 trillion yuan by 2025 [3] - The sixth batch of high-value medical consumables procurement has concluded, with results to be announced today [1]

Core Viewpoint - The company is planning to strengthen its strategic partnership with CATL by issuing shares to introduce CATL as a strategic investor, while terminating a major asset restructuring plan [1][4]. Group 1: Share Issuance and Financial Details - The company intends to raise approximately 3.175 billion yuan through a share issuance at a price of 13.62 yuan per share, with a total of 233,149,124 shares to be issued [1]. - The funds raised will be allocated to various projects, including a 500,000-ton high-end lithium iron phosphate project, key components for electric drive systems, and robotic integration projects [2]. Group 2: Strategic Business Transformation - The company is transitioning from traditional precision processing to smart control and mechatronics, aiming to enhance its capabilities in the robotic joint sector and engage in humanoid robot applications [3]. - The partnership with CATL is expected to deepen the collaboration within the supply chain and support the company's strategic goals of becoming a leader in lithium iron phosphate and intelligent control [3]. Group 3: Termination of Major Asset Restructuring - The decision to terminate the major asset restructuring was made to enhance the strategic partnership with CATL and to facilitate deeper cooperation in the new energy sector [4]. - The company will continue to hold a controlling interest in Jiangxi Shenghua, which remains a subsidiary, while the restructuring was initially aimed at equity cooperation at the project company level [5].

Core Viewpoint - Tongling Technology has faced ongoing challenges regarding its actual control and governance structure, which have hindered its IPO attempts over the years [1][2][3]. Group 1: Company Background and IPO Attempts - Tongling Technology was listed on the New Third Board in November 2015 and has made multiple attempts to go public, including submissions to the Shanghai Stock Exchange and Shenzhen Stock Exchange, all of which were unsuccessful until its recent submission to the Beijing Stock Exchange in June 2024 [1]. - The company has been struggling with issues related to the identification of its actual controller, which has been a significant concern for regulators and investors [2][3]. Group 2: Shareholding Structure and Control Issues - The actual controllers of Tongling Technology are identified as Xiang Chunchao, Xiang Jianwu, and Xiang Jianwen, who collectively hold 30.73% of the shares. Xiang Chunchao, along with 23 other shareholders, has formed a concerted action group controlling 75.88% of the voting rights [2][3]. - The transfer of shares from the founding shareholder Jiang Desheng to Xiang Chunchao and his family members has raised questions about the company's governance and control, particularly regarding the alignment of interests among major shareholders [3][4]. Group 3: Financial Performance - Tongling Technology's main business involves the research, production, and sales of automotive interior components, with significant clients including major automotive manufacturers such as Volkswagen and BYD [6]. - The company reported revenues of 8.92 billion yuan in 2022, 10.13 billion yuan in 2023, and projected 10.66 billion yuan for 2024, with net profits of 645.64 million yuan, 1.12 billion yuan, and 1.31 billion yuan respectively. The compound annual growth rate of net profit from 2022 to 2024 is 43.38% [6].

登录新浪财经APP 搜索【信披】查看更多考评等级 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担个别及连带责任。 重要内容提示: ●本次拟拍卖的股份为公司原控股股东新海新持有的公司28,557,200股无限售流通股，约占公司总股本 的5.82%。 以上具体内容详见公司披露的《关于控股股东所持部分股份将被司法拍卖的提示性公告》等相关公告 （公告编号：2024-071、2024-073、2024-084、2025-083、2025-098）。 三、其他相关说明及风险提示 1、截至本公告日，本次司法拍卖事项尚在公示阶段，后续将涉及竞拍、缴款、股权变更过户等环节， 拍卖结果尚存在不确定性。 1、拍卖标的:西藏新海新创业投资有限公司持有的公司28,557,200股股票（无限售流通股） 2、展示起拍价：11794.1236万元（起拍价以发布日前20个交易日的收盘价均价（MA20）*70%确定） 3、保证金：1200万元 4、增价幅度：58万元 二、新海新股份之前被司法拍卖的情况 ●本次司法拍卖事项尚在公示阶段，后续将涉及竞拍、缴款、股权变更过户等环 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 关于招商利安新兴亚洲精选交易型开放式指数证券投资基金（QDII）2026年境外主要投资市场节假日 和非交易日暂停申购、赎回业务的公告 为保护基金份额持有人的利益，保障基金平稳运作，根据《招商利安新兴亚洲精选交易型开放式指数证 券投资基金（QDII）基金合同》《招商利安新兴亚洲精选交易型开放式指数证券投资基金（QDII）招 募说明书》的相关规定及境外主要投资市场节假日安排，招商利安新兴亚洲精选交易型开放式指数证券 投资基金（QDII）（证券简称：新兴亚洲，扩位证券简称：新兴亚洲ETF，证券代码：520580）因2026 年1月16日至2026年1月19日为境外主要投资市场节假日和非交易日将暂停申购、赎回业务，并于2026年 1月20日恢复办理上述业务。 若境外主要投资市场节假日和非交易日安排发生变化，本公司将进行相应调整并公告。 如有疑问，请拨打客户服务热线：400-887-9555，或登录网站www.cmfchina.com获取相关信息。 特此公告。 招商基金管理有限公司 2026年1月13日 关于暂停招商安瑞进取债券型证券投资基金大额申购（含定期定额投资）和 ...

Core Viewpoint - The announcements detail the share reduction activities of major shareholders of Suzhou Medisun Medical Technology Co., Ltd., including the results of share reductions by major shareholders and the management of idle raised funds [1][2][8]. Shareholder Reduction Summary - Major shareholder Mr. Weng Kang held 20,857,003 shares, representing 6.81% of the total share capital before the reduction plan [1]. - Mr. Weng Kang's reduction plan involved selling up to 5,214,250 shares, not exceeding 25% of his holdings or 1.70% of the total share capital, from October 16, 2025, to January 15, 2026 [1]. - As of January 12, 2026, Mr. Weng Kang successfully reduced his holdings by 5,213,800 shares, accounting for 1.70% of the total share capital [1]. - Mr. Wu Di planned to reduce his holdings by up to 14,250 shares, not exceeding 25% of his holdings or 0.0047% of the total share capital, during the same period [2]. - Mr. Wu Di successfully reduced his holdings by 14,200 shares, representing 0.0046% of the total share capital [2]. Compliance and Issues - Mr. Weng Kang's share reduction included an incident on December 17, 2025, where he mistakenly increased his holdings by 10,900 shares, constituting a short-term trading behavior [2]. - The company board has emphasized the importance of compliance with trading regulations to prevent similar occurrences in the future [2]. Fund Management Summary - The company approved a plan to manage idle raised funds of up to RMB 200 million for cash management, ensuring it does not affect project progress or fund safety [5]. - As of December 31, 2025, the company redeemed a bank deposit of RMB 90 million, earning a return of RMB 22,500 [6]. - The remaining balance of idle raised funds for cash management was RMB 15 million, with no overdue products reported [6].

登录新浪财经APP 搜索【信披】查看更多考评等级 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性依法承担法律责任。 重要内容提示： ● 会议召开时间：2026年1月16日（星期五）上午9:00-10:00 ●会议召开地点：上海证券交易所上证路演中心（网址：http://roadshow.sseinfo.com/） ● 会议召开方式：上证路演中心网络互动 ● 投资者可于2026年1月13日（星期二）至1月15日（星期四）16:00前登录上证路演中心网站首页点 击"提问预征集"栏目或通过公司邮箱（jlzqb@unionman.com.cn）进行提问。公司将在说明会上对投资者 普遍关注的问题进行回答。 广东九联科技股份有限公司（以下简称"公司"或"九联科技"）已于2026年1月10日发布《广东九联科技 股份有限公司关于终止筹划重大资产重组的公告》（公告编号：2026-001），为便于广大投资者更全面 深入地了解本次终止筹划重大资产重组交易事项，公司计划于2026年1月16日（星期五）上午9:00-10:00 举行关于召开终止筹划重大资产重组投资者 ...